Certara’s latest earnings call painted a cautiously balanced picture for investors. Management highlighted solid full-year metrics, including healthy revenue growth, expanding software sales and ...

Certara (NASDAQ:CERT) executives used a fireside chat at the TD Cowen Health Care Conference to outline early priorities under new CEO Jon Resnick, discuss the company’s ongoing strategic review of ...

Leerink Global Healthcare Conference 2026 March 9, 2026 8:00 AM EDTCompany ParticipantsJohn Gallagher - SVP, Principal ...

Certara, Inc. (NASDAQ:CERT) is one of the 14 oversold value stocks to invest in right now. Certara, Inc. (NASDAQ:CERT) enjoys ...

Certara displayed positive results in 3M. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately 10.33%. This indicates a nota ...

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Firstly, we'll want to see a proven return on capital ...

The London Company, an investment management company, released “The London Company Small Cap Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter, ...

A private equity firm said it was buying an additional 30 million shares of Certara. The company is seeing strong growth in its software products. Revenue in the third quarter was up 15% year over ...

Certara Inc’s stock reached a new 52-week low, hitting 8.02 USD, marking a significant milestone for the company in a challenging year. The stock has plummeted 14.26% in the past week alone, according ...

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp Limited announces its acquisition (subject to certain closing conditions) by Certara, a leading provider of drug discovery and development software and ...

PRINCETON, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), today announced it has acquired Vyasa Analytics, LLC. Vyasa provides scalable deep-learning software which allows life ...